USPTO serial 79455221
ENSILICATION
Reviewed by CopyMark Law Group
Status 640Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- NKOJO, RHODA K
- Law office
- TMO LAW OFFICE 117
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with ENSILICATION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Additives (chemical -) for use in enzyme stabilisation; catalysts for chemical and biochemical processes; biological activators; raw chemicals; chemical substances, chemical materials and chemical preparations; chemical adjuvants for use in industry and science; chemicals for use in the manufacture of pharmaceuticals; chemicals for use in biotechnological product development; biological preparations for use in industry; chemical substances for use in the biochemical industry; biological preparations for use in science; biological preparations for use in industry and science. | ACTIVE | — |
| 010 | Medical and veterinary apparatus and instruments; medical instruments; medical devices; medical analytical apparatus for medical purposes; medical instruments for therapeutic drug monitoring; apparatus for veterinary purposes. | ACTIVE | — |
| 042 | Scientific and technological services and research and design relating thereto; biological and biotechnological research and analysis; product research and development; product development in the field of vaccines and vaccine research; research and development relating to pharmaceutical, biotech and vaccine products and technologies; research and development relating to drug substances, adjuvants and medicines; research and development in the field of stabilisation of biological components; development and exploitation of protective silica nanoshells for the protection and/or delivery of biological components; biotechnology testing; design and implementation of biological analysis tests in the field of vaccine research; testing of drug substances and products for the pharmaceutical, biotech and vaccine sectors; consultancy services relating to pharmaceuticals, vaccines and biotechnology; consultancy services relating to research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants; provision of medical research information in the field of pharmaceuticals, biotechnology, adjuvants and vaccines; advisory services relating to research and development of pharmaceutical, biotech and vaccine products. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 21, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 20, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 12, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 11, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 11, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 30, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |